Penpulimab in combination with lenalidomide and R-GemOx regimen (R2-GemOx-PD1i) in relapsed or refractory diffuse large B-cell lymphoma: a multicenter, single-arm, phase 2 trial. - Liang JH; Xing TY; Gu WY; Yin H; Zeng QS; Du KX; Sibusiso L; Wu JZ; Li Y; Wang F; Gao R; Li JY; et al. (BMC medicine, 2026)